C & C Vision, Inc. – Trademark Portfolio
Entity Type: 03
C & C Vision, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CRYSTALENS. The owner is based in Aliso Viejo, CA.
6 Journey, Suite #270
Aliso Viejo, CA 92656
Showing of trademarks Trademarks
Trademark Classifications
C & C Vision, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does C & C Vision, Inc. have?
C & C Vision, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned.
What trademark classes does C & C Vision, Inc. file in?
C & C Vision, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 40 (Treatment & Processing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are C & C Vision, Inc.'s most well-known trademarks?
C & C Vision, Inc.'s registered trademark portfolio includes well-known marks such as CRYSTALENS. These are among 1 currently registered trademark in the portfolio.
What is C & C Vision, Inc.'s trademark registration success rate?
C & C Vision, Inc. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.